This summary and comparison of 2015 breast cancer screening recommendations from the American Cancer Society and US Preventive Services Task Force highlights the importance of a favorable benefit to harm ratio in the creation of mammography screening guidelines.
This study of data pooled from 5 mammography registries found that computer-aided detection (CAD) does not improve diagnostic accuracy of mammography, and these results suggest that insurers pay more for CAD with no established benefit to women.
This ecological study using data from the SEER cancer registries examines the associations between rates of mammography screening and the incidence of breast cancer, mortality from breast cancer, and tumor size.
This Viewpoint considers that breast density notification laws are unlikely to improve our understanding of breast cancer risk, screening, and diagnosis or to save lives and instead may result in substantial personal harms and societal costs.
This Viewpoint reports crowdsourced health care prices in California.
Tosteson et al measure the effect of false-positive mammograms on quality of life by measuring personal anxiety, health utility, and attitudes toward future screening. See also the invited commentary by Kroenke.
Using international standards, Schonberg et al developed and evaluated a mammography screening decision aid (DA) for women 75 years and older. See the Special Communication by Welch and Passow.
Welch and Passow quantify the benefit-harm trade-off for screening mammography
Wernli et al describe patterns of breast magnetic resonance imaging use in US community practice during the period 2005 through 2009.
Fowler et al surveyed how patients 40 years and older describe the decision-making process for 10 common medical decisions, including 6 that are most often made in primary care. See the Invited Commentary by Lipkin.